Key result
In vivo microCT-derived fat volume strongly correlated with ex vivo tissue weight for both visceral (R2=0.95, p<0.001) and subcutaneous (R2=0.91, p<0.001) fat pads in mice.
Why the study?
Does in vivo microCT accurately quantify subcutaneous and visceral adiposity compared to ex vivo tissue weight in mice?
Does in vivo microCT accurately quantify subcutaneous and visceral adiposity compared to ex vivo tissue weight in mice?
Effect estimate: R2=0.95 for visceral fat
p-value: p=<0.001
In vivo microCT is a highly accurate, non-invasive tool for quantifying total, visceral, and subcutaneous adiposity in mouse models.
microCT supports accurate noninvasive adiposity assessment in mice; extends preclinical tools but leaves open human translation.
Accurate and precise techniques that identify the quantity and distribution of adipose tissue in vivo are critical for investigations of adipose development, obesity, or diabetes. Here, we tested whether in vivo micro-computed tomography (microCT) can be used to provide information on the distribution of total, subcutaneous and visceral fat volume in the mouse. Ninety C57BL/6J mice (weight range: 15.7-46.5 g) were microCT scanned in vivo at 5 months of age and subsequently sacrificed. Whole body fat volume (base of skull to distal tibia) derived from in vivo microCT was significantly (p<0.001) correlated with the ex vivo tissue weight of discrete perigonadal (R(2)=0.94), and subcutaneous (R(2)=0.91) fat pads. Restricting the analysis of tissue composition to the abdominal mid-section between L1 and L5 lumbar vertebrae did not alter the correlations between total adiposity and explanted fat pad weight. Segmentation allowed for the precise discrimination between visceral and subcutaneous fat as well as the quantification of adipose tissue within specific anatomical regions. Both the correlations between visceral fat pad weight and microCT determined visceral fat volume (R(2)=0.95, p<0.001) as well as subcutaneous fat pad weight and microCT determined subcutaneous fat volume (R(2)=0.91, p<0.001) were excellent. Data from these studies establish in vivo microCT as a non-invasive, quantitative tool that can provide an in vivo surrogate measure of total, visceral, and subcutaneous adiposity during longitudinal studies. Compared to current imaging techniques with similar capabilities, such as microMRI or the combination of DEXA with NMR, it may also be more cost-effective and offer higher spatial resolutions.
No takes yet. Share an insight, caveat, or question.
Luu et al. (2008) studied Adiposity (n=90). In vivo micro-computed tomography (microCT) vs. Ex vivo tissue weight was evaluated on Correlation between in vivo microCT fat volume and ex vivo tissue weight (R2=0.95 for visceral fat, p=<0.001). In vivo microCT-derived fat volume strongly correlated with ex vivo tissue weight for both visceral (R2=0.95, p<0.001) and subcutaneous (R2=0.91, p<0.001) fat pads in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: